Cefoselis

This classification denotes a cephalosporin antibiotic with the molecular formula C19H22N8O6S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0B50MLU3H1, chemically known as (-)-5-amino-2-(((6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-(2-hydroxyethyl)pyrazolium hydroxide, inner salt, 7,2-(z)-(o-methyloxime). but generally known as cefoselis, which bears US NIH Compound Identifier 9589475. European Medicines Agency schedules Cefoselis in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07404MIG. The term CEFOSELIS is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). CEFOSELIS is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cefoselis under HS 29419000 and SITC 54139. As of Q4 2014, CEFOSELIS remains the US FDA Preferred Term for this commodity. Cefoselis bears US NLM identifiers UMLS ID C0965645 and NCI Concept Code C79420. SMILES: S1C2N(C(=O)C2NC(=O)/C(=N/OC)C2NC(SC2)N)C(=C(C1)C[N]1N(C(N)CC1)CCO)C(=O)O.